You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Algorithm Performance Evaluation with Low Sample Size

    SBC: Signature Research, Inc.            Topic: NGA20C001

    The team of Signature Research, Inc. and Michigan Technological University will develop and demonstrate methods and metrics to evaluate the performance of machine learning-based computer vision algorithms with low numbers of samples of labeled EO imagery. We will use the existing xView panchromatic dataset to demonstrate a proof-of-concept set of tools. If successful, in Phase II, we will extend t ...

    STTR Phase I 2021 Department of DefenseNational Geospatial-Intelligence Agency
  2. Neurofeedback Training and Hyperscanning for Mission Readiness and Return-to-Duty via Functional Near-Infrared Spectrometry (fNIRS)

    SBC: SOAR TECHNOLOGY INC            Topic: DHA19B001

    Until now,much of theresearch usingfunctional near-infrared spectroscopy (fNIRS) has focused on tailoringasystem to detect onlyafew cognitivestatesand theapplication of theseapproaches outsidethe laboratory is not well tested. This solution provides severely limited coverage of thespacethat this technology could beapplied to,and is notarealistic path for developing neuroimagingasan operational ass ...

    STTR Phase I 2020 Department of DefenseDefense Health Agency
  3. Virus-Like Particle Based pan-Marburgvirus Vaccine

    SBC: Luna Innovations Incorporated            Topic: CBD18A002

    Marburg virus (MARV) is a filamentous enveloped non-segmented negative sense RNA virus. This viruse is considered to be extremelydangerous with case fatality rates as high as 88-90%. Extensive efforts have gone towards effective vaccines for MARV prevention, however,none have been successfully established as licensed vaccines. Glycoprotein (GP) is the only surface protein of MARV. There are substa ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  4. Algorithms for Look-down Infrared Target Exploitation

    SBC: Signature Research, Inc.            Topic: 1

    Signature Research, Inc. (SGR) and Michigan Technological University (MTU) propose a Phase I STTR effort to develop a learning algorithm which exploits the spatio-spectral characteristics inherent within IR imagery and motion imagery.Our archive of modelled and labeled data sets will allow our team to thoroughly capture the variable elements that will drive machine learning performance.The overall ...

    STTR Phase I 2018 Department of DefenseNational Geospatial-Intelligence Agency
  5. Functionalized, Therapeutic-Loaded Liposomes for the Acute Treatment of TBI

    SBC: Luna Innovations Incorporated            Topic: DHA18A001

    Traumatic brain injury is a common problem in both the military and civilian communities, but current treatment protocols are focused on managing symptoms and fail to prevent significant long-term repercussions. In the proposed program, Luna will demonstrate the feasibility of a liposome-based therapeutic delivery system capable of delivering hydrophilic and hydrophobic therapeutics to the traumat ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  6. Probabilistic Pharmacokinetic Models for Diagnosis, Prognosis, and Personalized Treatment

    SBC: BARRON ASSOCIATES, INC.            Topic: DHA17B003

    Clinicians have recognized that the nature of diseases can be highly individual resulting in different patterns of onset and progression. In turn, the response of an individual to drugs is also unique and governed by a variety of factors. Pharmacokinetic models represent the movement of a drug through the body, and personalized pharmacokinetic models aim to capture the unique responses of specific ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  7. Griffon Test Suite

    SBC: SOAR TECHNOLOGY INC            Topic: DHA17C001

    In this proposal we support the development of a hypoxia test battery by designing and developing a domain general tool suite for processing, synchronizing, and evaluating data from cognitive, behavioral, and physiological measures.The proposed Griffon Tool Suite addresses many of the practical requirements demanded by a flexible test battery. The effort falls into three major thrusts.First, we pr ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  8. Combat Casualty Handoff Automated Trainer (CCHAT)

    SBC: SOAR TECHNOLOGY INC            Topic: DHA17B001

    Combat casualty handoffs are critical communication moments during which responsibility for the patient and important casualty information is transferred between providers. The nature of these handoffs requires specialized training, for which no standardized framework currently exists. The proposed effort aims to develop a capability, compatible with current DoD systems, that provides caregivers w ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  9. CCHAT Handoff Protocol

    SBC: SOAR TECHNOLOGY INC            Topic: DHA17B002

    Research has identified that handoffs are particularly important communication processes, during which communication error can lead to patient safety situations. Organizations have created standard practices and training materials to encourage teamwork communication for handoffs, however these do not necessarily capture the needs of military medicine of combat casualty care. Combat casualty handof ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  10. Developing Software for Pharmacodynamics and Bioassay Studies

    SBC: TConneX Inc.            Topic: DHP16C001

    Estimation of the primary parameters like IC 50 in traditional dose-response modelsmay fail or lead to misleading results when the observations are non-onotonic due to drugresistance or virus mutation in various biomedical lab research. The objective of this project isto develop a novel approach to assess dose response relationship, which is applicable to generalpharmacologic, toxicologic, or othe ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government